4-Amino-3-Iodo-1H-Pyrazolo[3,4-d]pyrimidinum CAS 151266-23-8 Ibrutinib puritate media >98.5% (HPLC)
Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum 4-Amino-3-Iodo-1H-Pyrazolo[3,4-d]pyrimidinei (CAS: 151266-23-8) magna qualitate.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com
Nomen chemicum | 4-Amino-3-Iodo-1H-Pyrazolo[3,4-d]pyrimidine |
Synonyma | 3-Iodo-1H-Pyrazolo[3,4-d]pyrimidin-4-Amine;4-Amino-3-Iodopyrazolo[3,4-d]pyrimidine;(3-Iodo-1H-Pyrazolo[3,4-d]pyrimidin-4-yl)amine;3-iodo-4-Amino-1H-Pyrazolo[3,4-d]pyrimidine |
CAS Number | 151266-23-8 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C5H4IN5 |
M. Pondus | 261.03 |
Liquescens punctum | >300℃ |
Density | 2.92±0.0 g/cm3 |
λmax | 282nm(lit.) |
Sensitiva | lux Sensitiva |
COA & MSDS | Praesto |
Origin | Shanghai, China |
Brand | Ruifu Chemical |
Item | Specifications | Specifications |
Aspectus | Lumen Yellow Pulvis | Lumen Yellow Pulvis |
Puritas / Analysis Methodus | >98.5% (HPLC) | 98.87% |
Damnum in Siccatio | <0.50% | 0.41% |
Totalis immunditias | <1.50% | 1.13% |
Infrared Imaginis | Conformat ut Structure | Conforms |
1H NMR Imaginum | Conformat ut Structure | Conforms |
Test Standard | Enterprise Standard | Conforms |
Consuetudinem | Medium Ibrutinib (CAS: 936563-96-1) |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Quam mercari?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Russiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Periculosam symbola Xn - Noxia
Periculum Codes
R36/37/38 - Irritando ad oculos, systema respiratorium et cutem.
R22 - noxia absorptus
Salus Descriptio
S26 - In contactu cum oculis, statim cum aqua multa ablue et consilium medicinae quaeras.
S36/37/39 - Indumentum tutelae idoneum, caestus et oculi/facies tutelam gerunt.
S37 - gere idoneis caestibus.
TSCA N
HS Codicis 2933599099
4-Amino-3-Iodo-1H-Pyrazolo[3,4-d]pyrimidinum (CAS: 151266-23-8) medium est Ibrutinib (CAS: 936563-96-1).Ibrutinib est genus tyrosine kinase bruton (BTK) inhibitoris, adhiberi potest ad curationem lymphocyticam longam leukemia (CLL) et pallium cellae lymphomae (MCL).MCL et CLL ad lymphoma B-celluli Hodgkin non pertinebant, quod difficile est curare et facile recurrere.Commune chemicum immunotherapyrum scopum non habet, saepe occurrit motus 3 vel 4 adversas.Ibrutinib et B lymphocytes oppugnare potuerunt cum BTK, quae ad informationem, differentiationem et transmissionem necessaria sunt, BTK actionem irreversibiliter inhibent, et tumorem cellularum proliferation et efficaciter superstes inhibent.